Published in Proc Natl Acad Sci U S A on August 16, 2004
Cellular and molecular mechanisms of pain. Cell (2009) 9.36
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet (2014) 4.24
Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest (2005) 3.17
The Na(V)1.7 sodium channel: from molecule to man. Nat Rev Neurosci (2012) 2.71
Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol (2010) 2.71
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest (2007) 2.58
Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature (2011) 2.31
The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain (2007) 2.06
Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. Mol Pain (2005) 1.86
Nociceptors: the sensors of the pain pathway. J Clin Invest (2010) 1.72
Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun (2012) 1.72
Neurological perspectives on voltage-gated sodium channels. Brain (2012) 1.62
Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. Neuron (2008) 1.52
Ion channels as drug targets: the next GPCRs. J Gen Physiol (2008) 1.51
Pain without nociceptors? Nav1.7-independent pain mechanisms. Cell Rep (2014) 1.50
GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9. J Physiol (2007) 1.49
The cell biology of touch. J Cell Biol (2010) 1.45
State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine. Mol Pharmacol (2007) 1.38
A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol (2007) 1.35
Pain as a channelopathy. J Clin Invest (2010) 1.33
Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol Pain (2011) 1.32
Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Mol Pain (2008) 1.26
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A (2006) 1.26
Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J Physiol (2005) 1.24
Pain genes. PLoS Genet (2008) 1.23
Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain (2011) 1.23
Sodium channelopathies and pain. Pflugers Arch (2010) 1.22
Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol Pain (2006) 1.21
Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy. Mol Pain (2009) 1.19
Differential methylation of the TRPA1 promoter in pain sensitivity. Nat Commun (2014) 1.19
Excitability parameters and sensitivity to anemone toxin ATX-II in rat small diameter primary sensory neurones discriminated by Griffonia simplicifolia isolectin IB4. J Physiol (2009) 1.16
Subtype-selective targeting of voltage-gated sodium channels. Br J Pharmacol (2009) 1.13
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J Neurosci (2008) 1.13
Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain (2012) 1.11
Pain channelopathies. J Physiol (2010) 1.09
Ion channels in inflammation. Pflugers Arch (2011) 1.08
A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr Opin Anaesthesiol (2011) 1.08
Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol Pain (2012) 1.07
Understanding inflammatory pain: ion channels contributing to acute and chronic nociception. Pflugers Arch (2010) 1.02
Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches. Behav Pharmacol (2011) 1.02
Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain. PLoS One (2014) 1.02
Nav1.7 expression is increased in painful human dental pulp. Mol Pain (2008) 1.00
Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain. J Clin Invest (2013) 0.99
Functional properties and toxin pharmacology of a dorsal root ganglion sodium channel viewed through its voltage sensors. J Gen Physiol (2011) 0.98
Pain hypersensitivity mechanisms at a glance. Dis Model Mech (2013) 0.98
Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7. Mol Pain (2007) 0.96
An in vivo tethered toxin approach for the cell-autonomous inactivation of voltage-gated sodium channel currents in nociceptors. J Physiol (2010) 0.96
Autonomic renal denervation ameliorates experimental glomerulonephritis. J Am Soc Nephrol (2008) 0.96
Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A (2012) 0.95
Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells. J Physiol (2015) 0.95
Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain. Eur J Pain (2010) 0.95
Selective silencing of Na(V)1.7 decreases excitability and conduction in vagal sensory neurons. J Physiol (2011) 0.95
Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse. Mol Pain (2011) 0.94
Genes and epigenetic processes as prospective pain targets. Genome Med (2013) 0.93
Epigenetics and the transition from acute to chronic pain. Pain Med (2012) 0.93
Aquaporin-1 tunes pain perception by interaction with Na(v)1.8 Na+ channels in dorsal root ganglion neurons. J Biol Chem (2009) 0.91
Sodium channels and mammalian sensory mechanotransduction. Mol Pain (2012) 0.91
Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7. Nat Commun (2015) 0.91
Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice. PLoS One (2014) 0.91
Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics (2009) 0.91
AMPK: An emerging target for modification of injury-induced pain plasticity. Neurosci Lett (2013) 0.91
Significant determinants of mouse pain behaviour. PLoS One (2014) 0.91
Challenges in the development of novel treatment strategies for neuropathic pain. NeuroRx (2005) 0.90
Sodium channel beta1 regulatory subunit deficiency reduces pancreatic islet glucose-stimulated insulin and glucagon secretion. Endocrinology (2008) 0.90
Block of persistent late Na+ currents by antidepressant sertraline and paroxetine. J Membr Biol (2008) 0.89
A multi PDZ-domain protein Pdzd2 contributes to functional expression of sensory neuron-specific sodium channel Na(V)1.8. Mol Cell Neurosci (2009) 0.89
Repetitive activity slows axonal conduction velocity and concomitantly increases mechanical activation threshold in single axons of the rat cranial dura. J Physiol (2011) 0.89
Protein kinase B/Akt is required for complete Freund's adjuvant-induced upregulation of Nav1.7 and Nav1.8 in primary sensory neurons. J Pain (2013) 0.89
Identification of molecular pathologies sufficient to cause neuropathic excitability in primary somatosensory afferents using dynamical systems theory. PLoS Comput Biol (2012) 0.88
Electroacupuncture Reduces Carrageenan- and CFA-Induced Inflammatory Pain Accompanied by Changing the Expression of Nav1.7 and Nav1.8, rather than Nav1.9, in Mice Dorsal Root Ganglia. Evid Based Complement Alternat Med (2013) 0.88
Tetrodotoxin (TTX) as a therapeutic agent for pain. Mar Drugs (2012) 0.87
Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. J Physiol (2014) 0.87
Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons. Mol Pain (2011) 0.86
Na(+) channel blockers for the treatment of pain: context is everything, almost. Exp Neurol (2007) 0.85
A chronic pain: inflammation-dependent chemoreceptor adaptation in rat carotid body. Respir Physiol Neurobiol (2011) 0.85
Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opin Ther Targets (2016) 0.84
Na(v) 1.8-null mice show stimulus-dependent deficits in spinal neuronal activity. Mol Pain (2006) 0.84
Modeling nociception in zebrafish: a way forward for unbiased analgesic discovery. PLoS One (2015) 0.84
A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. J Physiol (2013) 0.84
Knockout of Slo2.2 enhances itch, abolishes KNa current, and increases action potential firing frequency in DRG neurons. Elife (2015) 0.84
Synthetic ciguatoxins selectively activate Nav1.8-derived chimeric sodium channels expressed in HEK293 cells. J Biol Chem (2009) 0.83
Candidate hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression. Mol Cell Proteomics (2012) 0.83
Dexmedetomidine and clonidine inhibit the function of Na(v)1.7 independent of α(2)-adrenoceptor in adrenal chromaffin cells. J Anesth (2011) 0.83
Regulation of firing frequency in nociceptive neurons by pro-inflammatory mediators. Exp Brain Res (2009) 0.83
Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models. ACS Med Chem Lett (2016) 0.83
Novel mRNA isoforms of the sodium channels Na(v)1.2, Na(v)1.3 and Na(v)1.7 encode predicted two-domain, truncated proteins. Neuroscience (2008) 0.82
Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain. Neurotherapeutics (2009) 0.82
Thermosensory and mechanosensory perception in human genetic disease. Hum Mol Genet (2009) 0.81
The role of sodium channels in chronic pain. Muscle Nerve (2012) 0.81
Ranolazine attenuates behavioral signs of neuropathic pain. Behav Pharmacol (2009) 0.81
Post-translational modifications of voltage-gated sodium channels in chronic pain syndromes. Front Pharmacol (2015) 0.80
Sensory-Evoked Intrinsic Imaging Signals in the Olfactory Bulb Are Independent of Neurovascular Coupling. Cell Rep (2015) 0.80
The molecular basis of pain and its clinical implications in rheumatology. Nat Clin Pract Rheumatol (2009) 0.79
An approach to identify microRNAs involved in neuropathic pain following a peripheral nerve injury. Front Neurosci (2014) 0.79
Nav1.7 protein and mRNA expression in the dorsal root ganglia of rats with chronic neuropathic pain. Neural Regen Res (2012) 0.79
Evaluation of behavior and expression of NaV1.7 in dorsal root ganglia after sciatic nerve compression and application of nucleus pulposus in rats. Eur Spine J (2013) 0.78
Probing functional properties of nociceptive axons using a microfluidic culture system. PLoS One (2013) 0.78
Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a. Sci Rep (2017) 0.78
Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia. PLoS One (2015) 0.77
Mouse DRG Cell Line with Properties of Nociceptors. PLoS One (2015) 0.77
Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet (1999) 55.63
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol (2002) 13.87
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 12.21
From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron (2000) 9.51
Subregion- and cell type-restricted gene knockout in mouse brain. Cell (1996) 8.02
Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci (2003) 7.44
Widespread recombinase expression using FLPeR (flipper) mice. Genesis (2001) 7.08
Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature (2001) 6.26
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
Impaired pressure sensation in mice lacking TRPV4. J Biol Chem (2003) 3.59
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 3.45
Mutation of a new sodium channel gene, Scn8a, in the mouse mutant 'motor endplate disease'. Nat Genet (1995) 2.99
Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci U S A (1997) 2.75
The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol (2003) 2.59
Acid-sensing ion channels ASIC2 and ASIC3 do not contribute to mechanically activated currents in mammalian sensory neurones. J Physiol (2004) 2.48
Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci (2002) 2.24
Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther (2002) 2.12
A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem (1997) 1.91
Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature (2002) 1.88
Role of the sensory neuron cytoskeleton in second messenger signaling for inflammatory pain. Neuron (2003) 1.82
Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. Biophys J (2000) 1.79
Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein. J Physiol (2003) 1.75
A role for the TTX-resistant sodium channel Nav 1.8 in NGF-induced hyperalgesia, but not neuropathic pain. Neuroreport (2001) 1.74
Involvement of Na+ channels in pain pathways. Trends Pharmacol Sci (2001) 1.58
Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A (2002) 1.52
Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A (1999) 1.50
Brief expression of a GFP cre fusion gene in embryonic stem cells allows rapid retrieval of site-specific genomic deletions. Nucleic Acids Res (1997) 1.30
Conditional gene knockout using Cre recombinase. Mol Biotechnol (2001) 1.28
Modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by protein kinase A and protein kinase C. J Neurophysiol (2003) 1.27
The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32. Am J Hum Genet (2001) 1.24
Cloning and characterization of a mouse sensory neuron tetrodotoxin-resistant voltage-gated sodium channel gene, Scn10a. Genomics (1997) 1.08
Nav2/NaG channel is involved in control of salt-intake behavior in the CNS. J Neurosci (2000) 1.06
Accumulation of PN1 and PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry. Acta Neurochir (Wien) (2002) 1.04
Regulation of cell surface expression of voltage-dependent Nav1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cells. Front Biosci (2004) 1.00
Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J Neurochem (2003) 0.97
Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects. Life Sci (2003) 0.94
Attenuation of pro-inflammatory neuropeptide levels produced by a cyclooxygenase-2 inhibitor in an animal model of chronic temporomandibular joint inflammation. J Orofac Pain (2002) 0.84
Sodium channels in primary sensory neurons: relationship to pain states. Novartis Found Symp (2002) 0.84
An SCN9A channelopathy causes congenital inability to experience pain. Nature (2006) 7.01
Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA (2006) 4.18
SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron (2006) 3.96
The cell and molecular basis of mechanical, cold, and inflammatory pain. Science (2008) 3.46
A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron (2010) 3.31
Parallel "pain" pathways arise from subpopulations of primary afferent nociceptor. Neuron (2005) 3.03
Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures. Nature (2007) 2.71
The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol (2003) 2.59
Acid-sensing ion channels ASIC2 and ASIC3 do not contribute to mechanically activated currents in mammalian sensory neurones. J Physiol (2004) 2.48
Distinct mechanosensitive properties of capsaicin-sensitive and -insensitive sensory neurons. J Neurosci (2002) 2.40
KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci (2003) 2.40
Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system. Pain (2012) 2.34
Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature (2011) 2.31
Genetic variation in SCN10A influences cardiac conduction. Nat Genet (2010) 2.30
The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons. Nat Neurosci (2012) 2.28
Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci (2002) 2.24
VGLUT2-dependent sensory neurons in the TRPV1 population regulate pain and itch. Neuron (2010) 2.22
Human visceral afferent recordings: preliminary report. Gut (2010) 2.15
Voltage-gated sodium channels and pain pathways. J Neurobiol (2004) 1.97
Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci (2004) 1.91
Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain (2011) 1.90
Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature (2002) 1.88
Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. Mol Pain (2005) 1.86
Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. Anesthesiology (2005) 1.80
The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci (2009) 1.73
Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun (2012) 1.72
Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice. Pain (2005) 1.72
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care (2013) 1.62
Remote optogenetic activation and sensitization of pain pathways in freely moving mice. J Neurosci (2013) 1.62
GTP-induced tetrodotoxin-resistant Na+ current regulates excitability in mouse and rat small diameter sensory neurones. J Physiol (2003) 1.62
Neurological perspectives on voltage-gated sodium channels. Brain (2012) 1.62
Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain (2006) 1.61
The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol (2003) 1.54
Neural coding of nociceptive stimuli-from rat spinal neurones to human perception. Pain (2013) 1.54
Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain (2005) 1.54
Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. Neuron (2008) 1.52
GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9. J Physiol (2007) 1.49
Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients. Pain (2011) 1.49
Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J Neurosci (2002) 1.48
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet (2011) 1.39
High-threshold mechanosensitive ion channels blocked by a novel conopeptide mediate pressure-evoked pain. PLoS One (2007) 1.38
Modulation of sensory neuron mechanotransduction by PKC- and nerve growth factor-dependent pathways. Proc Natl Acad Sci U S A (2006) 1.38
Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract (2008) 1.38
Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J Neurosci (2008) 1.34
Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis. Proc Natl Acad Sci U S A (2013) 1.34
Pain as a channelopathy. J Clin Invest (2010) 1.33
Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J Neurosci (2010) 1.28
Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res (2004) 1.26
Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics (2009) 1.26
Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev (2012) 1.25
Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin. Pain (2008) 1.25
Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Mol Cell Neurosci (2006) 1.24
The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain. Pain Med (2011) 1.23
Pain genes. PLoS Genet (2008) 1.23
Animal models of bone cancer pain: systematic review and meta-analyses. Pain (2013) 1.22
Differential role of N-type calcium channel splice isoforms in pain. J Neurosci (2007) 1.22
Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol Pain (2006) 1.21
Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology. Anesthesiology (2011) 1.21
Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain. Mol Pain (2009) 1.21
Formalin-induced behavioural hypersensitivity and neuronal hyperexcitability are mediated by rapid protein synthesis at the spinal level. Mol Pain (2009) 1.19
Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study. Anesth Analg (2003) 1.19
Increasingly irritable and close to tears: TRPA1 in inflammatory pain. Cell (2006) 1.18
Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. J Biol Chem (2006) 1.18
Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain (2006) 1.17
Excitability parameters and sensitivity to anemone toxin ATX-II in rat small diameter primary sensory neurones discriminated by Griffonia simplicifolia isolectin IB4. J Physiol (2009) 1.16
Genetic tracing of Nav1.8-expressing vagal afferents in the mouse. J Comp Neurol (2011) 1.16
TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells. Open Biol (2012) 1.16
GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain. J Neurosci (2010) 1.15
Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling. EMBO J (2012) 1.15
Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol (2013) 1.14
Characterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritis. PLoS One (2012) 1.14
FM1-43 is a permeant blocker of mechanosensitive ion channels in sensory neurons and inhibits behavioural responses to mechanical stimuli. Mol Pain (2007) 1.12
Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. Eur J Pain (2008) 1.12
Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior. J Neurosci (2006) 1.11
Kinetic properties of mechanically activated currents in spinal sensory neurons. J Physiol (2009) 1.10
Pain channelopathies. J Physiol (2010) 1.09
Intrinsic neuronal excitability is reversibly altered by a single experience in fear conditioning. J Neurophysiol (2009) 1.09
Mammalian target of rapamycin signaling in the spinal cord is required for neuronal plasticity and behavioral hypersensitivity associated with neuropathy in the rat. J Pain (2010) 1.09
Annexin II light chain p11 promotes functional expression of acid-sensing ion channel ASIC1a. J Biol Chem (2005) 1.08
Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK. J Neurosci (2010) 1.06